Actively Recruiting
Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis
Led by University Hospital, Montpellier · Updated on 2025-07-10
76
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Montpellier
Lead Sponsor
H
Hôpital Cochin
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study evaluates a diagnostic serological test for Non-Tuberculous Mycobacteria (NTM) infection in cystic fibrosis patients by measuring T cell response. It aims to highlight a dynamic response associated to the pathogen's presence. This multicenter case-control study involves two populations, providing a better understanding of the circulating T-IFNγ-MNT response in these patients.
CONDITIONS
Official Title
Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient 63;18 years old
- Previously included in the CIMeNT study
- Confirmed diagnosis of cystic fibrosis regardless of CFTR genotype
- Affiliated to the social security system
- Registered in the French Cystic Fibrosis Registry
- Adult patient capable of spontaneous expectoration or after induction
You will not qualify if you...
- Lung transplant patients
- Persons under judicial protection
- Pregnant and breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, France
Actively Recruiting
Research Team
R
Raphael CHIRON, MD
CONTACT
J
Jean-Louis HERRMANN, Pr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here